Experienced in Pancreatic Pseudocyst

Dr. Juan C. Mejia

Providence St Joseph Health
Providence Health And Services Mt
Missoula, MT
Experienced
in Pancreatic Pseudocyst
Specialties:General Surgery | Surgical Oncology | Transplant Surgery
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Juan Mejia is a General Surgeon and a Surgical Oncologist in Missoula, Montana. Dr. Mejia and is rated as an Experienced provider by MediFind in the treatment of Pancreatic Pseudocyst. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Small Bowel Resection. Dr. Mejia is currently accepting new patients.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Specialties
General Surgery
Surgical Oncology
Transplant Surgery
Licenses
Transplant Surgery in WA
Hospital Affiliations
St. Patrick Hospital
Providence St Mary Medical Center
Prov Sacred Hrt Med Ctr & Childs Hosp.
Bitterroot Health - Daly Hospital
Kadlec Regional Medical Center
Languages Spoken
English
Bahasa
Castilian
Spanish
Tamil
Thai
Vietnamese
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  PacificSource
  •  Cigna
  •  Premera
  •  Prominence Health
  •  Humana

Locations

PROVIDENCE HEALTH AND SERVICES MT
500 W Broadway St, Suite 310, Missoula, MT 59802
406-728-6520
Other Locations
PROVIDENCE HEALTH AND SERVICES WASHINGTON
415 6th St, Lewiston, ID 83501
208-743-2511
PROVIDENCE HEALTH AND SERVICES WASHINGTON
101 W 8th Ave, Spokane, WA 99204
PROVIDENCE HEALTH AND SERVICES WASHINGTON
1200 E Columbia Ave, Colville, WA 99114
509-684-3701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3

8 Total Publications

Routine frozen section during pancreaticoduodenectomy does not improve value-based care.
Routine frozen section during pancreaticoduodenectomy does not improve value-based care.
Journal: Surgery in practice and science
Published: April 18, 2022

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile